QSC EU

qsc-eu.com is a country and compound-targeted content network, not a storefront in its own right: the site's own sitemap.xml lists 77 URLs, all fetched and all HTTP 200 (33 country and region pages under /buy-peptides-*.html, 29 single-compound and blend pages, 7 category pages, 3 stack and protocol pages, an EU warehouse page, a UK warehouse page, the compounds catalog page, a self-hosted reviews page and the home page), and every purchase control on the pages read resolves off-domain to qscpeptide.com, landing on its /shop/, its /product-category/eu/, or a site search query for the compound. No cart, no checkout and no account system exists anywhere on qsc-eu.com itself. On certificates specifically: no PDF, image or linked document purporting to be a certificate of analysis loads from any URL on the domain. The retatrutide, tirzepatide, semaglutide and EU-warehouse pages each state a purity claim as plain running text in a details table, describing a threshold of at least 99 percent by HPLC together with the phrase Janoshik COA, with no certificate, lot number, batch code or verification link attached to that text on any page; on the UK-warehouse page the same threshold and lab name appear only in the head metadata and embedded JSON-LD, a search-snippet assertion never shown in the visible body. Fetched today: /retatrutide-eu.html, /tirzepatide-eu.html, /semaglutide-eu.html, /eu-warehouse.html, /uk-warehouse.html, /compounds.html, /buy-peptides-europe.html.

On the laboratory: the site names Janoshik Analytical Laboratories, described in its own details tables as independent and verifiable, but qsc-eu.com links to no certificate and no verification portal for that name anywhere I loaded. I attempted to load the lab's own domain, janoshik.com, twice today, once with curl and once with a scripted HTTP client carrying full browser headers; both attempts were stopped before any page content loaded by a Cloudflare bot-check that served a Just a moment interstitial and a 403 status. Per my operating rules I did not attempt to solve or bypass that challenge. A plain HTTP request to the same host on 2026-08-25 did connect and redirect to HTTPS, with response headers (X-Kinsta-Cache, X-Redirect-By: WordPress, a ki-Cache-Tag value) showing a live WordPress site on Kinsta hosting behind Cloudflare; a re-fetch of the same plain request the next day was instead served a Cloudflare challenge page with a 403 status and no origin headers, so the header observation is dated to that single earlier fetch. The domain is live infrastructure either way, but I could not read what the lab's own site states about itself. Janoshik is named independently by unrelated vendors elsewhere in this research corpus, which is corroborating context that the name is a recognized one in this market, not independent verification of the lab's own claims from today's fetch.

Prices and catalog read from the live site on 2026-08-25, shown throughout in a paired EUR and USD display that the compounds page states is not two independently set prices: EUR figures are described on-page as calculated from the USD figure at a fixed 0.92 conversion and labelled indicative, though both columns are rounded and the per-row ratio actually runs from roughly 0.895 to 0.944, so 0.92 is the page's description rather than the arithmetic of any single row, and the catalog header itself is dated Updated May 2026, roughly three months stale against today's fetch. /compounds.html lists 260 individually priced rows across eight category headers, one of them naming the compound class alongside a direct appetite and weight-management indication rather than mechanism alone, against a claimed 75-plus compounds in the same page's title and body text, so the 260 rows are milligram and kit-size variants of a smaller compound count rather than 260 distinct compounds. Of the 260 priced rows, every one is a 10-vial or 20-vial kit except a single 50-vial HGH kit, SKU QSC-HGH-10IU-50VIAL at EUR 640 (USD 700), and the three stack pages are flat-priced bundles rather than vial kits; no single-vial SKU was found anywhere on the domain. Retatrutide, the wave benchmark, is listed under Retatrutide Variants & EUR Prices on /retatrutide-eu.html: the 10mg row, SKU QSC-RETATRUTIDE-10MG-10VIAL, is priced at EUR 210 (USD 230) for a 10-vial kit with no smaller unit offered, an implied per-vial price near EUR 21 by simple division of the kit price, before any accounting for a repackaging or reconstitution step neither page describes. Other retatrutide rows on the same page: 5mg 10-vial kit EUR 170 (USD 190), 15mg 10-vial kit EUR 260 (USD 280), 20mg 10-vial kit EUR 280 (USD 300), a retatrutide-plus-cagrilintide 10mg blend 10-vial kit EUR 290 (USD 310), and a 10mg 20-vial kit at EUR 380 (USD 410); the page carries 14 retatrutide rows in all, re-read 2026-08-26, the eight others being 30mg 10-vial EUR 300 (USD 330), 60mg 10-vial EUR 450 (USD 490), 5mg 20-vial EUR 300 (USD 330), 15mg 20-vial EUR 470 (USD 510), 20mg 20-vial EUR 510 (USD 550), the blend 20-vial EUR 520 (USD 570), 30mg 20-vial EUR 560 (USD 610) and 60mg 20-vial EUR 860 (USD 930), a full spread of EUR 170 to EUR 860. Shipping is claimed as free and customs-free domestic delivery in 2 to 7 business days across 27 named EU countries plus the UK, Switzerland and Norway from what the site calls an EU domestic warehouse, though the UK warehouse page adds that a compound absent from UK stock ships instead from a China warehouse in 7 to 21 business days, so the domestic-only claim does not hold for every SKU in every market. No refund, return or shipping policy document exists on qsc-eu.com; the buying guide page instead points buyers to qscpeptide.com to place the order and to two external crypto payment guides for a beginner walk of Bitcoin and USDT payment. The home page's stock panel also disagrees with the priced catalog on strength for at least six compounds, listing retatrutide 50mg, semaglutide 30mg, Semax 30mg, AOD9604 10mg, HCG 6000 IU and 15000 IU, and a 2ml bacteriostatic water that no priced row carries, while the site's structured data describes a 200-plus compound catalog against 75-plus in the visible copy and roughly 80 distinct compound stems in the table itself, so no single page on the domain states the catalog accurately.

Two structural cautions beyond the missing documentation. First, qsc-eu.com carries no entity information of its own: no company name with an incorporation suffix, no registration number, no street address, no phone number and no email address on any of the 77 sitemap pages fetched, and there is no about, contact, terms, privacy or refund page anywhere in the site's navigation or footer; the only self-identification is a running footer line naming qsc-eu.com and qscpeptide.com together, and every purchase action leaves this domain for qscpeptide.com, which is the entity that actually takes payment and ships product. Second, the retatrutide page opens its product description with an unsourced clinical-trial-styled statistic, a stated Phase 2 trial percentage for body-mass change over a defined week count paired with a triple-receptor mechanism claim, positioned directly beside the purchase control with no citation, no trial registry number and no link to primary literature; the compounds page separately groups multiple SKUs, including a cagrilintide-plus-semaglutide blend, under a category and product-tag naming the appetite and weight-management indication outright rather than describing the compounds by mechanism alone. The catalog is also not peptide-only: /compounds.html prices a botulinum neurotoxin at 100 IU (10-vial kit EUR 280, USD 300; 20-vial kit EUR 510, USD 550) plus gonadotropins and multiple HGH SKUs, and /clavicular-ascension-stack.html sells a flat USD 2,000 twelve-compound bundle whose stated contents include testosterone cypionate and oxandrolone, described as shipping from the claimed EU warehouse, a materially different regulatory exposure than a peptide catalog alone. The domain's one reputation surface, /qsc-reviews.html, is a sitemap-only page linked from no navigation, reproducing 111 forum posts dated October 2025 to March 2026 under a self-declared perfect five-star aggregate attributed to a named outside forum, with no verifiable identifiers behind any quote and no structured rating data behind the aggregate; it names an individual by first name as the order contact for US and Australian orders, and one quoted post describes an oral tablet at a stated 70mg strength, a dosage form absent from the priced catalog. Payment terms stated on this domain are internally inconsistent: most pages state Bitcoin and USDT (on both ERC-20 and TRC-20) only, plus a SWIFT wire route the buying guide describes as settling in Tether, but two sitemap-only regional pages linked from no other page, /buy-peptides-scandinavia.html and /buy-peptides-eastern-europe.html, state that bank transfer, cryptocurrency (Bitcoin, USDT, USDC) and credit or debit card are accepted, a card claim no other page makes and one that cannot be tested from this domain since no payment is taken here. The site also operates a declared sibling network far larger than its visible footer: a JSON-LD Organization block present on every sitemap page lists 25 affiliated domains under sameAs, spanning country storefronts for the US, UK, Australia, Canada and Asia, a clinic-branded domain, several single-indication shop domains and one domain naming anabolic steroids outright, of which the visible footer links four (clavicularpeptides.com, clavicularpeptide.com, midasmill.com and qscpeptidelab.com). Separately, eight language folders on qsc-eu.com itself (/de/, /es/, /fr/, /it/, /nl/, /pl/, /pt/, /sv/), each holding at least eight live pages, are declared only through hreflang tags in the head of eight English pages, appear in no sitemap and are linked from no visible page body, putting the true page count near 140; all of it is a programmatic multi-domain, multi-language content operation funneling to the single qscpeptide.com checkout rather than one independent retailer. qscpeptide.com carries no research-raw or ledger record of its own as of this wave, its registry status recorded as screened and inactive, so it is documented here only as the operator this domain routes every purchase to, and is flagged for a separate full record rather than duplicated in this one.